94 related articles for article (PubMed ID: 16282724)
1. Pharmacogenetics and pharmacogenomics of anticancer agents.
Huang RS; Ratain MJ
CA Cancer J Clin; 2009; 59(1):42-55. PubMed ID: 19147868
[TBL] [Abstract][Full Text] [Related]
2. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Barretina J; Caponigro G; Stransky N; Venkatesan K; Margolin AA; Kim S; Wilson CJ; Lehár J; Kryukov GV; Sonkin D; Reddy A; Liu M; Murray L; Berger MF; Monahan JE; Morais P; Meltzer J; Korejwa A; Jané-Valbuena J; Mapa FA; Thibault J; Bric-Furlong E; Raman P; Shipway A; Engels IH; Cheng J; Yu GK; Yu J; Aspesi P; de Silva M; Jagtap K; Jones MD; Wang L; Hatton C; Palescandolo E; Gupta S; Mahan S; Sougnez C; Onofrio RC; Liefeld T; MacConaill L; Winckler W; Reich M; Li N; Mesirov JP; Gabriel SB; Getz G; Ardlie K; Chan V; Myer VE; Weber BL; Porter J; Warmuth M; Finan P; Harris JL; Meyerson M; Golub TR; Morrissey MP; Sellers WR; Schlegel R; Garraway LA
Nature; 2012 Mar; 483(7391):603-7. PubMed ID: 22460905
[TBL] [Abstract][Full Text] [Related]
3. Modeling cancer drug response through drug-specific informative genes.
Parca L; Pepe G; Pietrosanto M; Galvan G; Galli L; Palmeri A; Sciandrone M; Ferrè F; Ausiello G; Helmer-Citterich M
Sci Rep; 2019 Oct; 9(1):15222. PubMed ID: 31645597
[TBL] [Abstract][Full Text] [Related]
4. Inconsistency in large pharmacogenomic studies.
Haibe-Kains B; El-Hachem N; Birkbak NJ; Jin AC; Beck AH; Aerts HJ; Quackenbush J
Nature; 2013 Dec; 504(7480):389-93. PubMed ID: 24284626
[TBL] [Abstract][Full Text] [Related]
5. Tumor Chemosensitivity Assays Are Helpful for Personalized Cytotoxic Treatments in Cancer Patients.
Ulukaya E; Karakas D; Dimas K
Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34205407
[TBL] [Abstract][Full Text] [Related]
6. [Genomic markers and anticancer chemotherapy].
Nishiyama M
Gan To Kagaku Ryoho; 2008 Feb; 35(2):194-9. PubMed ID: 18281756
[TBL] [Abstract][Full Text] [Related]
7. Selection of a novel drug-response predictor in esophageal cancer: a novel screening method using microarray and identification of IFITM1 as a potent marker gene of CDDP response.
Fumoto S; Shimokuni T; Tanimoto K; Hiyama K; Otani K; Ohtaki M; Hihara J; Yoshida K; Hiyama E; Noguchi T; Nishiyama M
Int J Oncol; 2008 Feb; 32(2):413-23. PubMed ID: 18202764
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacogenetics in oncology: 5-fluorouracil and the dihydropyrimidine dehydrogenase].
Lazar A; Jetter A
Dtsch Med Wochenschr; 2008 Jul; 133(28-29):1501-4. PubMed ID: 18597209
[TBL] [Abstract][Full Text] [Related]
9. [Dihydropyrimidine dehydrogenase activity and its genetic aberrations].
Ogura K
Gan To Kagaku Ryoho; 2006 Aug; 33(8):1041-8. PubMed ID: 16912518
[TBL] [Abstract][Full Text] [Related]
10. [Polygenetic pharmacogenomic strategies to identify drug sensitivity biomarkers].
Nishiyama M
Gan To Kagaku Ryoho; 2005 Nov; 32(12):1902-7. PubMed ID: 16282724
[TBL] [Abstract][Full Text] [Related]
11. [Genome research and anticancer chemotherapy].
Hayashi I; Nishiyama M
Gan To Kagaku Ryoho; 2001 Sep; 28(9):1183-9. PubMed ID: 11579627
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]